EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Novavax (NASDAQ:NVAX) Trading Down 6.1% - What's Next?
Novavax (NASDAQ:NVAX) Trading Down 6.1% - Should You Sell? - Daily Political
Novavax (NASDAQ:NVAX) Trading 5.5% Higher - Here's What Happened
Novavax (NASDAQ:NVAX) Stock Price Up 5.5% - Still a Buy? - Stock Observer
Why Novavax (NVAX) Is Up 9.2% After Singapore Backs Nuvaxovid And Analysts Hike Estimates
Is Novavax (NVAX) A Potential Opportunity After Recent Vaccine Market Volatility?
Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Analysts Conflicted on These Healthcare Names: Stereotaxis (STXS) and Novavax (NVAX) | Markets Insider
Is Novavax (NVAX) Mispriced After Recent Share Rebound And DCF Upside Projection
Novavax Sees Unusually Large Options Volume (NASDAQ:NVAX)
Novavax Target of Unusually Large Options Trading (NASDAQ:NVAX) - Stock Observer
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Brokerages
Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 Sales
Novavax Covid-19 vaccine available at selected GP clinics in Singapore from Jan 2 to May 31
Novavax COVID-19 vaccine available at some GP clinics until May 31
Novavax (NVAX) Is Up 6.3% After Activist Sale Push and Sanofi-Focused Royalty Pivot - What's Changed - Simply Wall St News
Novavax (NVAX): Weighing Undervaluation Claims Against Fading Momentum and DCF Signals
Evaluating Novavax's Current Valuation After Steep Five Year Share Price Collapse
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
